Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 128 participants.
Also called NCT02215694
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose basic science
- Phase
- Phase 3
- Enrolled
- 128 participants
- Sponsor
- Registry
-
NCT02215694
-
- Other papers using this trial's data
- The triglyceride-lowering effect of supplementation with dual probiotic strains, Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032: Reduction of fasting plasma lysophosphatidylcholines in nondiabetic and hypertriglyceridemic subjects
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- South Korea
- Registry status
- Completed
Technical summary
Registry record NCT02215694. Randomized; double masking; primary purpose basic science. Start 2012-06 (registry gives no type); primary completion 2014-03 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Supplementation of Dual Probiotic Strains Reduced Fasting Triglyceride and Enhanced Apolipoprotein A-V Levels
- Condition
- Hypertriglyceridemia
- Intervention (Dietary supplement)
- dual probiotics
- Intervention (Dietary supplement)
- placebo
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct02215694- Content hash
3efdb37910d289f85046e1ddc22ab86a2cbbae7d3cf4d205e8b7f89a05551443